share_log

6-K: Novo Nordisk A/S - Share Repurchase Programme

6-K: Novo Nordisk A/S - Share Repurchase Programme

诺和诺德 | 6-K：诺和诺德-股票回购计划
美股SEC公告 ·  06/24 12:10

Moomoo AI 已提取核心信息

Novo Nordisk A/S, a leading global healthcare company, has reported progress on its share repurchase program. The company, headquartered in Denmark, initiated the program on May 6, 2024, as part of a larger DKK 20 billion buyback plan set to occur over a 12-month period starting February 6, 2024. As of June 24, 2024, Novo Nordisk has repurchased 1,150,040 B shares under the current program, with a total expenditure of DKK 1,082,466,722. The transactions were made between June 17 and June 21, 2024, with the number of shares purchased each day ranging from 36,000 to 36,500 at average prices between DKK 979.90 and DKK 986.99. Overall, since the beginning of the buyback period in February, the company has acquired 9,884,290 B shares at an average price of DKK 871.10 per share, amounting to a total spend of DKK 8,610,201,494. Novo Nordisk now holds 11,249,854 B shares as treasury shares, which is 0.3% of the share capital. The company's shares are traded on Nasdaq Copenhagen and its ADRs on the New York Stock Exchange.
Novo Nordisk A/S, a leading global healthcare company, has reported progress on its share repurchase program. The company, headquartered in Denmark, initiated the program on May 6, 2024, as part of a larger DKK 20 billion buyback plan set to occur over a 12-month period starting February 6, 2024. As of June 24, 2024, Novo Nordisk has repurchased 1,150,040 B shares under the current program, with a total expenditure of DKK 1,082,466,722. The transactions were made between June 17 and June 21, 2024, with the number of shares purchased each day ranging from 36,000 to 36,500 at average prices between DKK 979.90 and DKK 986.99. Overall, since the beginning of the buyback period in February, the company has acquired 9,884,290 B shares at an average price of DKK 871.10 per share, amounting to a total spend of DKK 8,610,201,494. Novo Nordisk now holds 11,249,854 B shares as treasury shares, which is 0.3% of the share capital. The company's shares are traded on Nasdaq Copenhagen and its ADRs on the New York Stock Exchange.
领先的全球医疗保健公司诺和诺德(Novo Nordisk A/S)在分享回购计划方面取得了进展。该公司总部位于丹麦，于2024年5月6日启动了该计划，作为总额为200亿丹麦克朗的回购计划的一部分，该计划将在2024年2月6日开始的12个月内实施。截至2024年6月24日，诺和诺德已在当前计划下回购了1,150,040股B股，总花费为10,824,667,22丹麦克朗。这些交易是在2024年6月17日至6月21日之间进行的，每天购买的股数在36,000至36,500之间，平均价格介于979.90丹麦克朗至986.99丹麦克朗之间。总体而言，自2月份回购期开始以来，该公司已以平均每股871.10丹麦克朗的价格收购了9,884,290股B股，总花费为86,102,014,94丹麦克朗。诺和诺德现持有11,249,854股B股作为库存股份，占总股本的0.3%。该公司的股票在纳斯达克哥本哈根上交易，其ADR在纽约证券交易所上市。
领先的全球医疗保健公司诺和诺德(Novo Nordisk A/S)在分享回购计划方面取得了进展。该公司总部位于丹麦，于2024年5月6日启动了该计划，作为总额为200亿丹麦克朗的回购计划的一部分，该计划将在2024年2月6日开始的12个月内实施。截至2024年6月24日，诺和诺德已在当前计划下回购了1,150,040股B股，总花费为10,824,667,22丹麦克朗。这些交易是在2024年6月17日至6月21日之间进行的，每天购买的股数在36,000至36,500之间，平均价格介于979.90丹麦克朗至986.99丹麦克朗之间。总体而言，自2月份回购期开始以来，该公司已以平均每股871.10丹麦克朗的价格收购了9,884,290股B股，总花费为86,102,014,94丹麦克朗。诺和诺德现持有11,249,854股B股作为库存股份，占总股本的0.3%。该公司的股票在纳斯达克哥本哈根上交易，其ADR在纽约证券交易所上市。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    热议
    美股
    股票代码最新价涨跌幅

    暂无数据

    资讯热榜
    更新时间